Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Balam Er Dedekarginoglu (Ankara, Turkey), Balam Er Dedekarginoglu, Fusun Eyuboglu, Ozlem Salman Sever, Aydincan Akdur, Mehmet Haberal. The value of interferon-gamma releasing assays (IGRA) determining latent tuberculosis infection in renal transplant candidates. Eur Respir J 2016; 48: Suppl. 60, 2105

Member's Comments

No comment yet.

Related content which might interest you: Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Interferon-γ release assays (IGRA) for detecting latent tuberculosis (LTBI) after lung transplantation (LTX) Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients Source: International Congress 2015 – Screening strategies in TB Year: 2015 Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB) Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection Source: International Congress 2015 – Latent TB infection and screening Year: 2015 Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Evaluation of IFNgamma release assays for detection of cellular immunity towards M. tuberculosis and CMV in samples from deceased donors Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009 Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007 Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases Source: Eur Respir J 2009; 33: 586-593 Year: 2009 The value of immunological methods in the diagnosis of tuberculosis in patients with HIV Source: International Congress 2015 – Screening strategies in TB Year: 2015 Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013